Quest Diagnostics, Montefiore Health Systems Partner
Quest Diagnostics is working with Montefiore Health System to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "As part of our strategy to accelerate growth and drive operational excellence, Quest is collaborating with an increasing number of hospital partners, including leading academic institutions like Montefiore, which are looking to focus on their core business by taking advantage of our expertise, innovation and scale."
Quest will perform a portion of low complexity diagnostic tests at its Teterboro, NJ lab facility. The remainder of the laboratory testing will continue to be done at Montefiore Hospitals under the direction of the Montefiore and Einstein Department of Pathology.
"Quest is a unique company committed to innovating new technologies and diagnostic capabilities," said Philip Ozuah, M.D., Ph.D., and Chief Operating Officer, Montefiore Health System. "Most importantly, this new venture will allow Montefiore to maintain its laser focus on improving patient care and outcomes, while teaming up with a leader in the field who has access to the most sophisticated diagnostic equipment available."
Personal Omics Data Informative for Precision Health and Preventive CareNews
Multi-omics profiling, the measurement and analysis of a person’s genome along with other biomolecular traits, is an important step toward personal health management that provides valuable, actionable information.READ MORE
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE